294 related articles for article (PubMed ID: 16990190)
1. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study.
Uhl W; Nolting A; Golor G; Rost KL; Kovar A
Clin Toxicol (Phila); 2006; 44 Suppl 1():17-28. PubMed ID: 16990190
[TBL] [Abstract][Full Text] [Related]
2. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade.
Fortin JL; Giocanti JP; Ruttimann M; Kowalski JJ
Clin Toxicol (Phila); 2006; 44 Suppl 1():37-44. PubMed ID: 16990192
[TBL] [Abstract][Full Text] [Related]
3. Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers.
Uhl W; Nolting A; Gallemann D; Hecht S; Kovar A
Clin Toxicol (Phila); 2008 Jul; 46(6):551-9; discussion 576-7. PubMed ID: 18584369
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.
Borron SW; Baud FJ; Barriot P; Imbert M; Bismuth C
Ann Emerg Med; 2007 Jun; 49(6):794-801, 801.e1-2. PubMed ID: 17481777
[TBL] [Abstract][Full Text] [Related]
5. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
6. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers.
Forsyth JC; Mueller PD; Becker CE; Osterloh J; Benowitz NL; Rumack BH; Hall AH
J Toxicol Clin Toxicol; 1993; 31(2):277-94. PubMed ID: 8492341
[TBL] [Abstract][Full Text] [Related]
7. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model.
Bebarta VS; Tanen DA; Lairet J; Dixon PS; Valtier S; Bush A
Ann Emerg Med; 2010 Apr; 55(4):345-51. PubMed ID: 19944487
[TBL] [Abstract][Full Text] [Related]
8. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamics after intraosseous administration of hydroxocobalamin or normal saline in a goat model.
Borron SW; Arias JC; Bauer CR; Sanchez M; Fernández M; Jung I
Am J Emerg Med; 2009 Nov; 27(9):1065-71. PubMed ID: 19931752
[TBL] [Abstract][Full Text] [Related]
10. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation.
Borron SW; Baud FJ; Mégarbane B; Bismuth C
Am J Emerg Med; 2007 Jun; 25(5):551-8. PubMed ID: 17543660
[TBL] [Abstract][Full Text] [Related]
11. Cyanide poisoning and cardiac disorders: 161 cases.
Fortin JL; Desmettre T; Manzon C; Judic-Peureux V; Peugeot-Mortier C; Giocanti JP; Hachelaf M; Grangeon M; Hostalek U; Crouzet J; Capellier G
J Emerg Med; 2010 May; 38(4):467-76. PubMed ID: 20185266
[TBL] [Abstract][Full Text] [Related]
12. Role of hydroxocobalamin in acute cyanide poisoning.
Shepherd G; Velez LI
Ann Pharmacother; 2008 May; 42(5):661-9. PubMed ID: 18397973
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
14. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
15. Hydroxocobalamin as a cyanide antidote.
DesLauriers CA; Burda AM; Wahl M
Am J Ther; 2006; 13(2):161-5. PubMed ID: 16645433
[No Abstract] [Full Text] [Related]
16. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
17. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?
Hall AH; Dart R; Bogdan G
Ann Emerg Med; 2007 Jun; 49(6):806-13. PubMed ID: 17098327
[TBL] [Abstract][Full Text] [Related]
18. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest.
Bebarta VS; Pitotti RL; Dixon PS; Valtier S; Esquivel L; Bush A; Little CM
Ann Emerg Med; 2012 Oct; 60(4):415-22. PubMed ID: 22424656
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
[TBL] [Abstract][Full Text] [Related]
20. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.
Garcia JM; Polvino WJ
Oncologist; 2007 May; 12(5):594-600. PubMed ID: 17522248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
